<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="dentistry" lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher">JOHS</journal-id>
<journal-id journal-id-type="nlm-ta">Journ of Health Scien</journal-id>
<journal-title-group>
<journal-title>Journal of HealthCare Sciences</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Journ of Health Scien</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">2231-2196</issn>
<issn pub-type="opub">0975-5241</issn>
<publisher>
<publisher-name>Radiance Research Academy</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">472</article-id>
<article-id pub-id-type="doi">http://dx.doi.org/10.52533/JOHS.2025.51212</article-id>
<article-id pub-id-type="doi-url"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Dentistry</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Infection Control Strategies in Maxillofacial Traumas and Prevention of Complications
</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>AlHammad</surname>
<given-names>Ziyad Abdulaziz</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bosaleh</surname>
<given-names>Alaa Hussin</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alghamdi</surname>
<given-names>Abdullah Khalaf</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aleidan</surname>
<given-names>Abdulbari Mohammed</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alqahtani</surname>
<given-names>Sultan Saeed</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alsoli</surname>
<given-names>Mona Abdulmohsen</given-names>
</name>
</contrib>
</contrib-group>
<pub-date pub-type="ppub">
<day>15</day>
<month>12</month>
<year>2025</year>
</pub-date>
<volume>5</volume>
<issue>12</issue>
<fpage>800</fpage>
<lpage>808</lpage>
<permissions>
<copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement>
<copyright-year>2009</copyright-year>
<license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p>
</license>
</permissions>
<abstract>
<p>Maxillofacial trauma is a serious issue that imposes a huge burden on healthcare systems worldwide. Etiology of maxillofacial trauma varies, with road traffic accidents being the most common cause. Its incidence varies between countries due to multiple factors, especially socioeconomic factors. Infection is a common complication for maxillofacial trauma, given the rich bacterial environment of this area. This infection can significantly worsen postoperative outcomes that may require more complex interventions. Types of maxillofacial trauma infection involve fracture-related infection (FRL) and surgical site infection (SSI), both of which can be prevented by infection control strategies. Various infection control strategies for maxillofacial surgeries were developed; however, the variability in infection control methods led to mixed results. This review aims to explore current evidence about infection control strategies in maxillofacial trauma and its effectiveness in reducing infection rates. Infection rates in maxillofacial trauma vary with mandibular fractures showing the highest infection rate. Antibiotic prophylaxis is the main infection control method, which showed effectiveness if it was administered within the first 24 hours following surgery, as exceeding this period has shown no additional benefits. Infection control strategies should consider risk factors, such as comorbidities and surgical factors. Future studies should focus on establishing harmonized guidelines based on robust data for infection control in maxillofacial trauma.
</p>
</abstract>
<kwd-group>
<kwd>Maxillofacial trauma</kwd>
<kwd> infection control</kwd>
<kwd> fracture-related infection</kwd>
<kwd> surgical site infection</kwd>
<kwd> antibiotics prophylaxis</kwd>
</kwd-group>
</article-meta>
</front>
</article>